Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

NCT01161160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GSK Biologicals' GSK2340274A (two different formulations)
BIOLOGICAL: GSK Biologicals' - GSK2340272A

Sponsor

GlaxoSmithKline